Parkinson and depression: review and outlook
G Laux - Journal of neural transmission, 2022 - Springer
Abstract Depression in Parkinson's Disorder (DPD) has been estimated to appear in up to
40% of people with PD and negatively impacts quality of life, motor and cognitive deficits …
40% of people with PD and negatively impacts quality of life, motor and cognitive deficits …
Inflammatory markers and depression in Parkinson's disease: a systematic review
LG Ramanzini, LFM Camargo, JOF Silveira… - Neurological …, 2022 - Springer
Background Parkinson's disease (PD) patients experience non-motor symptoms (NMS),
which may appear before motor manifestations. The most common NMS is depression …
which may appear before motor manifestations. The most common NMS is depression …
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease
Introduction Depression is one of the most disabling neuropsychiatric manifestations of
Parkinson's disease (PD) and requires proper screening and diagnosis because it affects …
Parkinson's disease (PD) and requires proper screening and diagnosis because it affects …
Efficacy of non-pharmacological interventions for depression in individuals with Parkinson's disease: A systematic review and network meta-analysis
Y Wang, X Sun, F Li, Q Li, Y Jin - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Background Depression in Parkinson's disease (PD) is a major health concern worldwide.
Recently, an increasing number of non-pharmacological interventions have been used in …
Recently, an increasing number of non-pharmacological interventions have been used in …
Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson's disease mouse model via suppressing hippocampal microglial …
Y Li, Q Yin, Q Li, A Huo, T Shen, J Cao, C Liu… - Acta Pharmacologica …, 2023 - nature.com
Depression is one of the common non-motor symptoms of Parkinson's disease (PD). In the
clinic, botulinum neurotoxin A (BoNT/A) has been used to treat depression. In this study, we …
clinic, botulinum neurotoxin A (BoNT/A) has been used to treat depression. In this study, we …
Prevalence and risk factors for malnutrition in patients with Parkinson's disease
T Yang, Z Zhan, L Zhang, J Zhu, Y Liu, L Zhang… - Frontiers in …, 2020 - frontiersin.org
Objectives: This study aimed to investigate the relationship between nutritional status and
Parkinson's disease (PD) features. Methods: The cohort was composed of 556 Parkinson's …
Parkinson's disease (PD) features. Methods: The cohort was composed of 556 Parkinson's …
miR-218-5p and miR-320a-5p as biomarkers for brain disorders: focus on the major depressive disorder and Parkinson's disease
Z Wan, M Rasheed, Y Li, Q Li, P Wang, J Li… - Molecular …, 2023 - Springer
Depression is one of the early and most persistent non-motor symptoms of Parkinson's
disease (PD), which remains ignored, resulting in the underdiagnosis of PD. Unfortunately …
disease (PD), which remains ignored, resulting in the underdiagnosis of PD. Unfortunately …
RNA methylations in depression, from pathological mechanism to therapeutic potential
C Li, P Xu, Y Huang, Y Wang, Y Wu, H Li… - Biochemical …, 2023 - Elsevier
Depression is caused by a variety of factors such as genetic factors, biological factors, and
psychosocial factors, and the pathogenesis is complex. RNA methylations and related …
psychosocial factors, and the pathogenesis is complex. RNA methylations and related …
Hydrogen sulfide attenuates depression-like behaviours in Parkinson's disease model rats by improving synaptic plasticity in a hippocampal warburg effect-dependent …
F Liu, Q Tian, HL Tang, X Cheng, W Zou… - Pharmacology …, 2024 - Elsevier
Background Depression is a highly prevalent comorbidity arising in patients with Parkinson's
disease (PD). However, depression in patients with PD is poorly treated. Hydrogen sulfide …
disease (PD). However, depression in patients with PD is poorly treated. Hydrogen sulfide …
Damaged insula network contributes to depression in Parkinson's disease
Background Depression is common in patients with Parkinson's disease (PD). Our previous
studies suggest that depressed PD patients have altered insula structures. It is, however, still …
studies suggest that depressed PD patients have altered insula structures. It is, however, still …